# CLNS1A

## Overview
The CLNS1A gene encodes the chloride nucleotide-sensitive channel 1A (ICln), a protein that plays a pivotal role in cellular ion homeostasis and volume regulation. ICln is categorized as an ion channel protein, facilitating the efflux of chloride ions in response to osmotic stress, thereby contributing to the regulatory volume decrease in cells. This protein is ubiquitously expressed across various cell types, underscoring its essential function in maintaining cellular homeostasis. Beyond its role in ion transport, ICln is involved in protein-protein interactions, notably with the PRMT5 complex and EIF4A2, implicating it in processes such as alternative splicing and translation initiation. The clinical significance of CLNS1A is particularly evident in cancer biology, where its amplification is associated with poor prognosis in luminal breast cancer, making it a potential target for therapeutic intervention (NoblejasLópez2021Genomic; Gschwentner1999Icln; Scandella2000The).

## Function
The CLNS1A gene encodes the ICln protein, which plays a crucial role in cell volume regulation and ion transport in healthy human cells. The ICln protein is involved in the activation of swelling-activated channels (SAC), which are essential for the regulatory volume decrease in cells following cytoplasmic swelling. This process involves the efflux of potassium and chloride ions, allowing cells to return to their normal size after swelling (Gschwentner1999Icln; Scandella2000The).

ICln functions as an ion channel, generating an outwardly rectifying chloride-selective current. This activity is crucial for maintaining cellular ion homeostasis and is regulated by the protein's transition from a soluble form in the cytosol to a membrane-bound form under hypotonic conditions, facilitating ionic currents (Gschwentner1999Icln; Scandella2000The). The protein is ubiquitously expressed across various species and cell types, indicating its vital role in cellular homeostasis (Gschwentner1999Icln).

In the absence of volume stress, ICln is primarily located in the cytosol, with a small fraction associated with the plasma membrane. Under osmotic stress, a significant portion relocates to the membrane, highlighting its role in responding to changes in extracellular osmolality (Gschwentner1999Icln).

## Clinical Significance
The CLNS1A gene has been implicated in various diseases and conditions due to its role in cellular processes. In the context of cancer, particularly luminal breast cancer, CLNS1A is frequently amplified, and its high expression levels are associated with poor prognosis, including reduced overall survival (OS) and relapse-free survival (RFS) in patients with Luminal A and B subtypes of breast cancer (NoblejasLópez2021Genomic). The amplification of CLNS1A is linked to oncogenic processes and treatment resistance, as it acts as a Sm chaperone, recruiting Sm proteins to the PRMT5 complex, which is crucial for cancer cell proliferation (NoblejasLópez2021Genomic).

Pharmacological interventions targeting CLNS1A, such as BET inhibitors, have shown promise in reducing its expression, leading to decreased cell proliferation in luminal breast cancer cell lines (NoblejasLópez2021Genomic). Downregulation of CLNS1A using siRNA in cell lines like MCF7 and T47D results in reduced cell proliferation and cell cycle arrest, highlighting its potential as a therapeutic target (NoblejasLópez2021Genomic). These findings suggest that CLNS1A plays a significant role in the pathogenesis of breast cancer and could serve as a prognostic marker and therapeutic target in this disease.

## Interactions
CLNS1A, or chloride nucleotide-sensitive channel 1A, is involved in various protein interactions that are significant for its function in cellular processes. It is known to interact with the PRMT5 complex by recruiting Sm proteins, acting as a Sm chaperone. This interaction is crucial for its role in alternative splicing, particularly in the context of luminal breast cancer, where its amplification is associated with poor prognosis (NoblejasLópez2021Genomic).

In addition to its role in splicing, CLNS1A has been identified as an interactor with EIF4A2, a protein involved in translation initiation. This interaction was discovered using the noDE-DDA method, which identified CLNS1A among other proteins interacting with EIF4A2, highlighting its potential involvement in protein-protein interaction networks (Zhang2022Mapping).

These interactions suggest that CLNS1A plays a role in complex cellular processes, including splicing and translation, by forming multiprotein complexes. Its involvement in these processes underscores its potential as a therapeutic target, particularly in cancer treatment, where modulation of its expression can have significant antiproliferative effects (NoblejasLópez2021Genomic).


## References


[1. (NoblejasLópez2021Genomic) María Noblejas-López, Igor López-Cade, Jesús Fuentes-Antrás, Gonzalo Fernández-Hinojal, Ada Esteban-Sánchez, Aránzazu Manzano, José García-Sáenz, Pedro Pérez-Segura, Miguel la Hoya, Atanasio Pandiella, Balázs Győrffy, Vanesa García-Barberán, and Alberto Ocaña. Genomic mapping of splicing-related genes identify amplifications in lsm1, clns1a, and ilf2 in luminal breast cancer. Cancers, 13(16):4118, August 2021. URL: http://dx.doi.org/10.3390/cancers13164118, doi:10.3390/cancers13164118. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13164118)

[2. (Gschwentner1999Icln) M. Gschwentner, J. Fürst, M. Ritter, C. Bazzini, E. Wöll, A. Dienstl, M. Jakab, M. König, E. Scandella, J. Rudzki, G. Botta, G. Meyer, F. Lang, P. Deetjen, and M. Paulmichl. Icln, an ion channel‐forming protein associated with cell volume regulation. Experimental Physiology, 84(6):1023–1031, November 1999. URL: http://dx.doi.org/10.1111/j.1469-445x.1999.01941.x, doi:10.1111/j.1469-445x.1999.01941.x. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/j.1469-445x.1999.01941.x)

[3. (Zhang2022Mapping) Shen Zhang, Brett Larsen, Karen Colwill, Cassandra J. Wong, Ji-Young Youn, and Anne-Claude Gingras. Mapping protein–protein interactions using data-dependent acquisition without dynamic exclusion. Analytical Chemistry, 94(30):10579–10583, July 2022. URL: http://dx.doi.org/10.1021/acs.analchem.2c00755, doi:10.1021/acs.analchem.2c00755. This article has 4 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1021/acs.analchem.2c00755)

[4. (Scandella2000The) Elke Scandella, Ulrich Olaf Nagl, Bernhard Oehl, Fredericke Bergmann, Martin Gschwentner, Johannes Fürst, Andreas Schmarda, Markus Ritter, Siegfried Waldegger, Florian Lang, Peter Deetjen, and Markus Paulmichl. The promoter for constitutive expression of the human icln gene clns1a. Journal of Biological Chemistry, 275(21):15613–15620, May 2000. URL: http://dx.doi.org/10.1074/jbc.275.21.15613, doi:10.1074/jbc.275.21.15613. This article has 2 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.275.21.15613)